Jingzhou Liu

发表

Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.

Steve Schneider, Xin Huang, John Newcomb, 2013, Journal of medicinal chemistry.

Species Difference in Glucuronidation Formation Kinetics with a Selective mTOR Inhibitor

L. Berry, Y. Teffera, Jingzhou Liu, 2014, Drug Metabolism and Disposition.

Application of on-line nano-liquid chromatography/mass spectrometry in metabolite identification studies.

Y. Teffera, Jingzhou Liu, Zhiyang Zhao, 2012, Rapid communications in mass spectrometry : RCM.

Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors.

H. Bregman, J. Newcomb, P. Andrews, 2013, Journal of medicinal chemistry.

Chemical reactivity of methoxy 4-o-aryl quinolines: identification of glutathione displacement products in vitro and in vivo.

B. Albrecht, J. Harmange, Y. Teffera, 2008, Chemical research in toxicology.

Aging erythrocyte membranes as biomimetic nanometer carriers of liver-targeting chromium poisoning treatment

Yang Yang, Jingzhou Liu, Qing Yao, 2021, Drug delivery.

Identification of quinone imine containing glutathione conjugates of diclofenac in rat bile.

Y. Teffera, Jingzhou Liu, Zhiyang Zhao, 2010, Chemical research in toxicology.

Impact of Hydrolysis-Mediated Clearance on the Pharmacokinetics of Novel Anaplastic Lymphoma Kinase Inhibitors

L. Berry, Y. Teffera, Jingzhou Liu, 2013, Drug Metabolism and Disposition.

Whole-body tissue distribution study of drugs in neonate mice using desorption electrospray ionization mass spectrometry imaging.

Y. Teffera, Jingzhou Liu, Zhiyang Zhao, 2014, Rapid communications in mass spectrometry : RCM.

Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET with High Unbound Target Coverage and Robust In Vivo Antitumor Activity.

K. Rex, A. Coxon, D. Whittington, 2016, Journal of medicinal chemistry.

Discovery of potent and selective 8-fluorotriazolopyridine c-Met inhibitors.

K. Rex, D. Whittington, S. Bellon, 2015, Journal of medicinal chemistry.

Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors.

T. Bush, A. Cheng, P. Andrews, 2012, Bioorganic & medicinal chemistry letters.